Results 161 to 170 of about 45,542 (206)

Targeting PRMT5 in Adult T-Cell Leukemia/Lymphoma: Opportunities and Challenges. [PDF]

Viruses
Ernzen K, Panfil AR.
europepmc   +1 more source

PRDM1 expression levels in marginal zone lymphoma and lymphoplasmacytic lymphoma [PDF]

, 2017
Hassan, Anjum, Hussaini, Mohammad, Mirza, Abu-Sayeef, Pfeifer, John, Yeung, Cecilia, Zhu, Xiaopei   +5 more
core   +1 more source

Automated Classification of Lymphoma Subtypes From Histopathological Images Using a U-Net Deep Learning Model: Comparative Evaluation Study.

JMIR Med Inform
Zhao J, Wen X, Ma L, Su L.
europepmc   +1 more source

Nanomedicines for Delivery of Cytarabine: Effect of Carrier Structure and Spacer on the Anti-Lymphoma Efficacy. [PDF]

Polymers (Basel)
Pola R, Grosmanová E, Pechar M, Kostka L, Pokorná E, Tušková L, Klener P, Etrych T.   +7 more
europepmc   +1 more source

Multifaceted cfDNA profiling in mantle cell lymphoma. [PDF]

Blood Adv
Sworder BJ, Herrera AF.
europepmc   +1 more source

R-CHOP and R-cytarabine for transplant-ineligible MCL. [PDF]

Blood Adv
Klener P, Tušková L, Blahovcová P, Trněný M.   +3 more
europepmc   +1 more source

The Pleiotropic Roles of Cytokines in Chimeric Antigen Receptor T-cell Therapy. [PDF]

Cancer Immunol Res
Stewart CM, Siegler EL, Kenderian SS.
europepmc   +1 more source

Beyond the CAR-T horizon in mantle cell lymphoma. [PDF]

Blood Adv
Lew TE, Seymour JF.
europepmc   +1 more source

Comparison of One-Year Adverse Events Between First- and Second-Generation Bruton's Tyrosine Kinase Inhibitors: A Retrospective Study. [PDF]

Cureus
Ito A, Ito K, Iriyama C, Goto N, Inamoto Y, Okamoto M, Hirose Y, Morisaku M, Yamada S, Hayakawa N, Tomita A.   +10 more
europepmc   +1 more source

mantle cell lymphoma

Annals of Oncology, 2008
openaire   +1 more source